Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,501 papers from all fields of science
Search
Sign In
Create Free Account
Metathesaurus Source Terminology Names
Known as:
SRC
, Source Terminology Names (UMLS)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
UMLS Metathesaurus
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
SRC fine‐tunes ADAM10 shedding activity to promote pituitary adenoma cell progression
Jinxiang Huang
,
Yuan Pan
,
+4 authors
Xuehua Ding
The FEBS Journal
2020
Corpus ID: 199055935
A disintegrin and metalloproteinase domain‐containing protein 10 (ADAM10) is a metalloproteinase known to modulate the…
Expand
2018
2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
S. Schuetze
,
V. Bolejack
,
+16 authors
L. Baker
JAMA Oncology
2018
Corpus ID: 14033316
Importance Gastrointestinal stromal tumors (GISTs) are life-threatening when metastatic or not amenable to surgical removal. In a…
Expand
Review
2013
Review
2013
Network analysis of neurotransmitter related human kinase genes: possible role of SRC, RAF1, PTK2B?
Z. Brys
,
András Pluhár
,
J. Kis
,
B. Buda
,
A. Szabo
Neuropsychopharmacologia Hungarica
2013
Corpus ID: 19253139
Previous co-expression analysis of human kinase genes highlighted 119 genes in neurotransmitter-related activity (based on Go…
Expand
2011
2011
Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Z. Hill
,
B. G. K. Perera
,
Dustin J Maly
Molecular Biosystems
2011
Corpus ID: 40793408
We recently reported a chemical genetic method for generating bivalent inhibitors of protein kinases. This method relies on the…
Expand
2009
2009
Technology: Indirect activation
M. Swami
Nature Reviews. Cancer
2009
Corpus ID: 9114728
Tyrosine kinase activation is an important oncogenic mechanism; however, it can be difficult to detect indirect mechanisms of…
Expand
Highly Cited
2006
Highly Cited
2006
Arrestin Serves as a Molecular Switch, Linking Endogenous α2-Adrenergic Receptor to SRC-dependent, but Not SRC-independent, ERK Activation*
Qin Wang
,
R. Lu
,
Jiali Zhao
,
L. Limbird
Journal of Biological Chemistry
2006
Corpus ID: 13554826
Our previous studies have demonstrated that neither receptor endocytosis nor arrestin is required for ERK activation by the α2…
Expand
1998
1998
Formation of a stable src–AFAP‐110 complex through either an amino‐terminal or a carboxy‐terminal SH2‐binding motif
Anne C. Guappone
,
Tracy Weimer
,
D. Flynn
Molecular Carcinogenesis
1998
Corpus ID: 10461528
The actin‐filament–associated protein (AFAP‐110) forms a stable complex with activated variants of the Pp60c‐src (Src) non…
Expand
Highly Cited
1992
Highly Cited
1992
Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation.
G. Twamley
,
R. Kypta
,
B. Hall
,
S. Courtneidge
Oncogene
1992
Corpus ID: 962050
Three members of the Src family of tyrosine kinases [pp60c-src (Src), p59fyn (Fyn) and pp62c-yes (Yes)] are ubiquitously…
Expand
1990
1990
Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
A. Tanaka
,
M. Salem
,
R. Eckroade
,
D. Fujita
Oncogene research
1990
Corpus ID: 12077494
We have isolated four activated transforming human c-src mutants derived spontaneously from viruses carrying the normal human c…
Expand
1990
1990
Properties of tripartite chimeras between Src and Lck.
A. Kashishian
,
A. Macauley
,
J. Cooper
Oncogene
1990
Corpus ID: 21181287
To evaluate the possible regulatory effects of interactions between different domains of Src-family kinases, we have assembled…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE